Assembly Biosciences Stock Price Prediction
| ASMB Stock | USD 13.33 0.41 3.17% |
Oversold Vs Overbought
60
Oversold | Overbought |
Assembly Biosciences stock price prediction is an act of determining the future value of Assembly Biosciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Assembly Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Assembly Biosciences and does not consider all of the tangible or intangible factors available from Assembly Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Assembly Biosciences, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Assembly Biosciences' stock price prediction:EPS Estimate Next Quarter (3.24) | EPS Estimate Current Year (14.88) | EPS Estimate Next Year (15.76) | Wall Street Target Price 36 | EPS Estimate Current Quarter (2.88) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Assembly Biosciences based on different types of headlines from major news networks to social media. The Assembly stock price prediction module provides an analysis of price elasticity to changes in media outlook on Assembly Biosciences over a specific investment horizon. Using Assembly Biosciences hype-based prediction, you can estimate the value of Assembly Biosciences from the perspective of Assembly Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Assembly Biosciences using Assembly Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Assembly using crowd psychology based on the activity and movement of Assembly Biosciences' stock price.
Assembly Biosciences Implied Volatility | 0.0 |
Assembly Biosciences' implied volatility exposes the market's sentiment of Assembly Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Assembly Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Assembly Biosciences stock will not fluctuate a lot when Assembly Biosciences' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Assembly Biosciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Assembly Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Assembly because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Assembly Biosciences after-hype prediction price | USD 13.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Assembly |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Assembly Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Assembly Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Assembly Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Assembly Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Assembly Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Assembly Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Assembly Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Assembly Biosciences' historical news coverage. Assembly Biosciences' after-hype downside and upside margins for the prediction period are 9.63 and 16.71, respectively. We have considered Assembly Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Assembly Biosciences is moderately volatile at this time. Analysis and calculation of next after-hype price of Assembly Biosciences is based on 3 months time horizon.
Assembly Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Assembly Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Assembly Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Assembly Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 3.54 | 0.16 | 0.03 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.33 | 13.17 | 1.20 |
|
Assembly Biosciences Hype Timeline
Assembly Biosciences is presently traded for 13.33. The entity has historical hype elasticity of -0.16, and average elasticity to hype of competition of 0.03. Assembly is expected to decline in value after the next headline, with the price expected to drop to 13.17. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.2%, whereas the daily expected return is presently at 0.5%. The volatility of related hype on Assembly Biosciences is about 5506.67%, with the expected price after the next announcement by competition of 13.36. About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Assembly Biosciences recorded a loss per share of 13.38. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 12th of February 2024. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Assembly Biosciences Basic Forecasting Models to cross-verify your projections.Assembly Biosciences Related Hype Analysis
Having access to credible news sources related to Assembly Biosciences' direct competition is more important than ever and may enhance your ability to predict Assembly Biosciences' future price movements. Getting to know how Assembly Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Assembly Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SPRO | Spero Therapeutics | 0.01 | 9 per month | 3.13 | (0) | 4.82 | (5.59) | 16.20 | |
| ACHL | Achilles Therapeutics PLC | (0.02) | 10 per month | 5.99 | (0) | 9.56 | (9.02) | 38.89 | |
| TIL | Instil Bio | (0.28) | 8 per month | 1.73 | 0.13 | 6.43 | (3.60) | 25.51 | |
| NLTX | Neoleukin Therapeutics | (0.12) | 2 per month | 0.00 | (0.04) | 6.67 | (5.67) | 15.97 | |
| CTMX | CytomX Therapeutics | 0.01 | 9 per month | 3.83 | 0.02 | 8.16 | (5.80) | 50.71 | |
| NUVB | Nuvation Bio | 0.70 | 9 per month | 4.03 | 0.12 | 16.67 | (6.50) | 46.16 | |
| NXTC | NextCure | 0.15 | 4 per month | 4.65 | 0.1 | 8.13 | (7.93) | 32.17 |
Assembly Biosciences Additional Predictive Modules
Most predictive techniques to examine Assembly price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Assembly using various technical indicators. When you analyze Assembly charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Assembly Biosciences Predictive Indicators
The successful prediction of Assembly Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Assembly Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Assembly Biosciences based on analysis of Assembly Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Assembly Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Assembly Biosciences's related companies. | 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.18 | 0.98 | 1.02 | Days Of Inventory On Hand | 8.11E-4 | 7.3E-4 | 7.67E-4 |
Story Coverage note for Assembly Biosciences
The number of cover stories for Assembly Biosciences depends on current market conditions and Assembly Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Assembly Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Assembly Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Assembly Biosciences Short Properties
Assembly Biosciences' future price predictability will typically decrease when Assembly Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Assembly Biosciences often depends not only on the future outlook of the potential Assembly Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assembly Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.6 M | |
| Cash And Short Term Investments | 130.2 M |
Check out Assembly Biosciences Basic Forecasting Models to cross-verify your projections. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.